Protect yourself from Coronavirus (COVID-19)

The best way to prevent the ongoing Coronavirus pandemic illness is by avoiding your exposure to the virus. Clean your hands often, use soap and water for at least 20 seconds or a hand sanitizer that contains at least 60% alcohol to clean your hands more frequently.
Avoid touching your eyes, nose and mouth with unwashed hands or after being in the public.
Avoid close contact with people who are sick. Maintain a safe distance between yourself and other people if COVID-19 is spreading in your community.
Stay home if you’re sick and take help from local health authorities and medical professionals.
Make sure to cover your mouth and nose with a tissue or use the inside of your elbow when you cough or sneeze. Properly dispose the used tissues in the trash, and immediately clean your hands with soap and water or a hand sanitizer.
Wear a face mask if you are sick or if you are around other people (e.g., sharing a room or vehicle) and before you enter a healthcare provider’s office. Do not wear a face mask unless you are caring for someone who is sick.

BlackBerry rumored to sell of the company or its parts by the end of November



According to a relevant source, the Canadian Mobile manufacturing giant, the BlackBerry is reportedly preparing to sell of the company by the end of this November.

We have heard it from a BlackBerry board member, that the company is in plans to sell some of it's pieces, also the BlackBerry special committee has already spoken to potentially interested parties, and began to short list the suitors. Reports also comes in claiming, that this special committee is interested in holding an auction, intentionally in plans of selling off the company. The former Sony Ericsson executive, who's now a member of BlackBerry's board, has said that the company should sell off pieces of itself and become a "niche" player. We can also consider the previous reports on BlackBerry Messenger application services preparing to sell off to a separate company.

Source: THE WALL STREET JOURNAL

0 comments: